Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for cilostazol in Related Substance Name (approximate match)

Showing 11 - 13 of 13 results

First page
Previous page
2
Next page disabled
Next page disabled

PLASMA PROTEIN FRACTION (HUMAN)

6D53G0FD0Z

Status:

US Approved Rx (2013)

Source:

BLA125416

(2013)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 1958

Source:

BLA101140

Source URL:

https://www.fda.gov/media/113210/download

Class:

MIXTURE

CGMP-INHIBITED 3',5'-CYCLIC PHOSPHODIESTERASE A

JOC85XIO65

Subunit 1 (1141) Similarity Search

Sequence Search

Subunit 1 (1141) Similarity Search

Status:

Other

Class:

PROTEIN

Cilostazol Dexborneol

463NWV9Y86

Search for Structure

Status:

US Approved Rx (2006)

Source:

ANDA077208

(2006)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077208

First approved in 1999

Source:

PLETAL by OTSUKA

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020863

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

Phosphodiesterase 3

Conditions:

Intermittent claudication

Cilostazol is a PDE3 inhibitor which is used for the treatment of intermittent claudication. The drug positively affects the platelet aggregation and may be used off-label as a measure to prevent coronary thrombosis/restenosis and stroke recurrence.

6D53G0FD0Z
Not a public record

Mixture

PLASMA PROTEIN FRACTION (HUMAN)

Protein

CGMP-INHIBITED 3',5'-CYCLIC PHOSPHODIESTERASE A

Structure of Cilostazol Dexborneol

ABSOLUTE

Cilostazol Dexborneol

Showing 11 - 13 of 13 results

First page
Previous page
2
Next page disabled
Next page disabled

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1